Regenxbio
RGNX
211 hedge funds and large institutions have $1.73B invested in Regenxbio in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 93 increasing their positions, 51 reducing their positions, and 17 closing their positions.
165% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 17
82% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 51
38% more capital invested
Capital invested by funds: $1.26B → $1.73B (+$476M)
15% more funds holding
Funds holding: 183 → 211 (+28)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.6% less ownership
Funds ownership: 83.54% → 82.94% (-0.6%)
57% less call options, than puts
Call options by funds: $9.38M | Put options by funds: $21.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$24.8M |
| 2 |
CG
Carmignac Gestion
Paris,
France
|
+$23.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.1M |
| 4 |
SG Americas Securities
New York
|
+$8.4M |
| 5 |
Bank of New York Mellon
New York
|
+$6.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$29.7M |
| 2 |
HCM
Highline Capital Management
New York
|
-$18.7M |
| 3 |
State Street
Boston,
Massachusetts
|
-$14.9M |
| 4 |
Morgan Stanley
New York
|
-$11.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.54M |
RGNX Hedge Fund Activity: Q1 2019 in Review
211 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q1 2019, worth a combined $1.73B — up 38% from $1.26B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new RGNX positions and 17 closed out — a net gain of 28 holders — while 93 added to existing stakes and 51 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $24.8M. The largest seller was RTW Investments, cutting an estimated $29.7M.
- 211 institutional investors held Regenxbio (RGNX) as of Q1 2019, up from 183 in Q4 2018.
- Funds reported $1.73B of Regenxbio stock for Q1 2019, up 38% quarter-over-quarter.
- 45 funds opened new Regenxbio positions in Q1 2019 and 17 closed out, a net change of +28 holders.
- The largest Regenxbio buyer in Q1 2019 was Perceptive Advisors, an estimated $24.8M added.
- The largest Regenxbio seller in Q1 2019 was RTW Investments, an estimated $29.7M sold.
Based on aggregated 13F filings for Q1 2019.